Moreover, these technological solutions face inherent limitations, including the frequent requirements for user inputs for meals and physical activities, risk of hypo-/hyperglycemia, burden of device maintenance, and a fundamental inability to replicate the precise, real-time, glucose-responsive insulin secretion of endogenous beta cells. Here, INS is linked to Hyperglycemia.